Skip to main content
Clinical Trials/JPRN-jRCT1080220913
JPRN-jRCT1080220913
Unknown
未知

A prospective observational study of the efficacy and safety of CPT-11 based regimens for UGT1A1 genotype guided patients with metastatic colorectal cancer

DAIICHI SANKYO COMPANY, LIMITED0 sites2,000 target enrollmentNovember 10, 2009

Overview

Phase
未知
Intervention
Not specified
Conditions
Metastatic colorectal cancer (adenocarcinoma)
Sponsor
DAIICHI SANKYO COMPANY, LIMITED
Enrollment
2000
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 10, 2009
End Date
TBD
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Metastatic colorectal cancer (adenocarcinoma)
  • 2\. Patients to receiving FOLFIRI, CPT\-11\+S\-1 and CPT\-11 alone therapy (with or without molecular targeted agents)
  • Age requirement none

Exclusion Criteria

  • 1\. Contraindications of CPT\-11
  • 2\. ECOG PS 3\-4
  • 3\. Patients to receiving CPT\-11 as adjuvant chemotherapy
  • 4\. History of a pelvic irradiation

Outcomes

Primary Outcomes

Not specified

Similar Trials